ApprovalTrail

Approval · Notice of Compliance 2995 · 1998

INDAPAMIDE: Notice of Compliance 2995

Issued February 5, 1998

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
2995
Date
February 5, 1998
Company
Bdh Inc.Toronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Therapeutic class
Diuretic/antihypertensive agent

Products in this notice

BrandDINStatus today
INDAPAMIDE02237255—

Medicinal ingredients